CNAT - Conatus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Conatus Pharmaceuticals's activity chart (see below) currently has 20 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 968.5 days.

Most recent stock forecast was given by from PIPER SANDLER on 26-Mar-2019. First documented stock forecast 19-Aug-2013.

Best performing analysts who are covering CNAT - Conatus Pharmaceuticals:

Charles Duncan Elemer Piros Ed Arce Stephen Willey Jay Olson Yasmeen Rahimi

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 22-Mar-2019

$8

$7.44 (1328.57%)

$14

Buy Since 06-Dec-2018

$10

$9.44 (1685.71%)

Hold Since 06-Dec-2018

$10

$9.44 (1685.71%)

Hold Since 24-Sep-2015

$5

$4.44 (792.86%)

$9

Show more analysts

Please expand the browser size to see the chart

What is CNAT (Conatus Pharmaceuticals) average time for price targets to be met?

On average it took 968.5 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on CNAT (Conatus Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on CNAT (Conatus Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 11 price targets and 9 ratings on CNAT

Which analyst is the currently most bullish on CNAT (Conatus Pharmaceuticals)?

Yasmeen Rahimi with highest potential upside - $19.44

Which analyst is the currently most reserved on CNAT (Conatus Pharmaceuticals)?

Charles Duncan with lowest potential downside - $4.44

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?